UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050518
Receipt number R000057420
Scientific Title A single-arm study to examine the effect of increased physical activity using a pedometer app with financial incentives.
Date of disclosure of the study information 2023/03/27
Last modified on 2023/09/21 16:22:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A single-arm study to examine the effect of increased physical activity using a pedometer app with financial incentives.

Acronym

A single-arm study to examine the effect of increased physical activity using a pedometer app with financial incentives.

Scientific Title

A single-arm study to examine the effect of increased physical activity using a pedometer app with financial incentives.

Scientific Title:Acronym

A single-arm study to examine the effect of increased physical activity using a pedometer app with financial incentives.

Region

Japan


Condition

Condition

Healthy volunteers with no exercise habits.

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To explore whether the use of a pedometer app with financial incentives can increase daily moderate-intensity physical activity time.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Difference between the first(app without financial incentives) and second(app with financial incentives) period in the number of successful attempts of challenge in a week

Key secondary outcomes

Difference between the first and second period of daily steps
Difference between the first and second period of daily walking distance
Difference between Period 1 and Period 2 in the proportion of participants with an average of 10 or more successful challenges in a week.
Difference between baseline and the first period of daily steps
Difference between baseline and the second period of daily steps
Difference between baseline and the first period of daily walking distance
Difference between baseline and the second period of daily walking distance
Difference between the first and second period of daily "heart points" measured by Google Fit


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Use of a smartphone app that measures moderate physical activity and provides financial incentives based on exercise time

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

60 years-old >=

Gender

Male and Female

Key inclusion criteria

1.able to walk independently without the use of a walking aid
2.have a BMI of at least 18 to 30.0 kg/m2, inclusive
3.able to communicate, read and write in Japanese
4.owns an iPhone and carries it on a daily basis
5.do not own a smartwatch, or if they do, are willing to consent to unpair their smartwatch from their iPhone during the study
6.can agree to provide step count and walking distance data up to 3 weeks prior to the day consent was obtained
7.can provide written consent to participate in the study of his/her own free will

Key exclusion criteria

1.already exercising at least 3 days a week
2.prohibited from exercising by a physician for any reason
3.systolic blood pressure 160 mmHg or higher or diastolic blood pressure 110 mmHg or higher at the time of inclusion
4.pregnant or lactating woman
5.judged by the investigator to be ineligible for participation in the study


Target sample size

15


Research contact person

Name of lead principal investigator

1st name Kosuke
Middle name
Last name Hayashi

Organization

Oita University Faculty of Medicine

Division name

Department of Clinical Pharmacology and Therapeutics

Zip code

8795593

Address

1-1 Idaigaoka, Hasama-Machi, Yufu-Shi, Oita, 879-5593 Japan

TEL

0975865952

Email

khayashi@oita-u.ac.jp


Public contact

Name of contact person

1st name Kosuke
Middle name
Last name Hayashi

Organization

Oita University Faculty of Medicine

Division name

Department of Clinical Pharmacology and Therapeutics

Zip code

8795593

Address

1-1 Idaigaoka, Hasama-Machi, Yufu-Shi, Oita, 879-5593 Japan

TEL

0975865952

Homepage URL


Email

khayashi@oita-u.ac.jp


Sponsor or person

Institute

Oita University Faculty of Medicine

Institute

Department

Personal name

Kosuke Hayashi


Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Oita University Hospital, Clinical Trial Ethics Committee

Address

1-1 Idaigaoka, Hasama-Machi, Yufu-Shi, Oita, 879-5593 Japan

Tel

0975866163

Email

gcrcjimu@oita-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 03 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

15

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 03 Month 07 Day

Date of IRB

2023 Year 03 Month 14 Day

Anticipated trial start date

2023 Year 04 Month 07 Day

Last follow-up date

2024 Year 06 Month 22 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 03 Month 07 Day

Last modified on

2023 Year 09 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057420


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name